CVRX - Why Is Heart Failure-Focused CVRx Stock Trading Higher Today? | Benzinga
CVRx Inc (NASDAQ: CVRX) announced that the Centers for Medicare and Medicaid Services (CMS) has reassigned the Barostim implant procedure for procedures performed in the outpatient setting as part of the 2024 Medicare Hospital Outpatient Prospective Payment System (OPPS) final rule.
Barostim is an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid ...